Comparing clinical and radiological effectiveness of disease modifying treatments in the real-world

被引：0

作者：

Moccia, M. ^{[1
]}

Al-Araji, S. ^{[1
]}

Zhang, L. ^{[1
]}

Abdel-Mannan, O. ^{[1
]}

Aojula, A. ^{[1
]}

Bianchi, A. ^{[1
]}

Champsas, D. ^{[1
]}

Eshaghi, A. ^{[1
]}

Goodkin, O. ^{[1
]}

Hamed, W. ^{[1
]}

Pontillo, G. ^{[1
]}

Yam, C. ^{[1
]}

Wilkins, D. ^{[1
]}

Brownlee, W. ^{[2
]}

Chard, D. ^{[2
]}

Chataway, J. ^{[2
]}

Chung, K. ^{[2
]}

De Angelis, F. ^{[2
]}

Khaleeli, Z. ^{[2
]}

Leary, S. ^{[2
]}

Swanton, J. ^{[2
]}

Thompson, A. ^{[2
]}

Toosy, A. T. ^{[2
]}

Trip, Sa. ^{[2
]}

Wilson, H. ^{[2
]}

Barkhof, F. ^{[3
]}

Ciccarelli, O. ^{[4
]}

机构：

[1] UCL, Queen Sq MS Ctr, Dept Neuroinflammat, UCL Queen Sq,Inst Neurol,Fac Brain Sci, London, England

[2] Natl Hosp Neurol & Neurosurg, London, England

[3] UCL, Translat Imaging Grp, UCL Inst Healthcare Engn, London, England

[4] UCL, Hosp Biomed Res Ctr, Nat Inst Hlth Res, London, England

来源：

MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

O018

引用

页码：10 / 11

页数：2

共 50 条

[1] Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data
Takabayashi, Katsuhiko
Ando, Fumihiko
Suzuki, Takahiro
MODERN RHEUMATOLOGY, 2019, 29 (01) : 87 - 97
[2] REAL-WORLD EFFECTIVENESS OF OSTEOPOROSIS TREATMENTS IN GERMANY
O'Kelly, J.
Bartsch, R.
Kossack, N.
Borchert, J.
Pignot, M.
Hadji, P.
VALUE IN HEALTH, 2020, 23 : S592 - S592
[3] Effectiveness of HCC treatments in real-world experiences
Misek, Glen I.
Keckeisen, Mark
Jayanti, Venkata K.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
[4] Real-world effectiveness of Pharmacological treatments in schizophrenia
Tiihonen, J.
Wahlbeck, K.
Lonngvist, J.
Klaukka, T.
Ioannidis, J. P. A.
Volavka, J.
Haukka, J.
EUROPEAN PSYCHIATRY, 2007, 22 : S55 - S56
[5] Real-world effectiveness of oral disease-modifying therapies for multiple sclerosis
Thanh Phuong Pham Nguyen
Thibault, Dylan
Willis, Allison
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 124 - 125
[6] Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
C. McArthur
C. Daruwalla
M. Jayeskara
J. W. L. Brown
Journal of Neurology, 2023, 270 : 5127 - 5129
[7] Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Mcarthur, C.
Daruwalla, C.
Jayeskara, M.
Brown, J. W. L.
JOURNAL OF NEUROLOGY, 2023, 270 (10) : 5127 - 5129
[8] Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study
Visram, Alissa
Chan, Kelvin Kar-Wing
Seow, Hsien
Pond, Gregory
Gayowsky, Anastasia
Mohyuddin, Ghulam Rehman
Mccurdy, Arleigh
Sandhu, Irwindeep
Venner, Christopher
Lancman, Guido
Balitsky, Amaris
Kouroukis, Tom
Bruins, Robert
Kumar, Shaji
Fonseca, Rafael
Mian, Hira
HAEMATOLOGICA, 2025, 110 (01) : 228 - 233
[9] Comparative Effectiveness and Safety of Disease-modifying Treatments (DMTs) in a Real-World Neuromyelitis Optica Spectrum Disorder Cohort (NMOSD)
Bilodeau, Phillippe-Antoine
Narasimhan, Sathya
Pua, Danielle Kei
Wruble, Mattia
Zhang, Ethan
Mateen, Farrah
Levy, Michael
Bhattacharyya, Shamik
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 142 - 142
[10] Comparative Effectiveness and Safety of Disease-modifying Treatments (DMTs) in a Real-World Neuromyelitis Optica Spectrum Disorder Cohort (NMOSD)
Bilodeau, Philippe-Antoine
Narasimhan, Sathya
Pua, Danielle Kei
Wruble, Mattia
Zhang, Yihan
Mateen, Farrah
Levy, Michael
Bhattacharyya, Shamik
NEUROLOGY, 2024, 103 (07) : S113 - S113

← 1 2 3 4 5 →